These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37495196)
1. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity. Houry D; Raasakka A; Ferrario E; Niere M; Bifulco E; Kursula P; Ziegler M J Struct Biol; 2023 Sep; 215(3):108004. PubMed ID: 37495196 [TBL] [Abstract][Full Text] [Related]
2. Structural insights into Xanthomonas campestris pv. campestris NAD Xu G; Ma J; Fang Q; Peng Q; Jiao X; Hu W; Zhao Q; Kong Y; Liu F; Shi X; Tang DJ; Tang JL; Ming Z Commun Biol; 2024 Mar; 7(1):255. PubMed ID: 38429435 [TBL] [Abstract][Full Text] [Related]
3. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. Hara N; Yamada K; Shibata T; Osago H; Tsuchiya M PLoS One; 2011; 6(8):e22781. PubMed ID: 21826208 [TBL] [Abstract][Full Text] [Related]
4. Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase. Burgos ES; Schramm VL Biochemistry; 2008 Oct; 47(42):11086-96. PubMed ID: 18823127 [TBL] [Abstract][Full Text] [Related]
5. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. Burgos ES Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631 [TBL] [Abstract][Full Text] [Related]
7. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240 [TBL] [Abstract][Full Text] [Related]
8. Identification of evolutionary and kinetic drivers of NAD-dependent signaling. Bockwoldt M; Houry D; Niere M; Gossmann TI; Reinartz I; Schug A; Ziegler M; Heiland I Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15957-15966. PubMed ID: 31341085 [TBL] [Abstract][Full Text] [Related]
10. Boosting NAD Gardell SJ; Hopf M; Khan A; Dispagna M; Hampton Sessions E; Falter R; Kapoor N; Brooks J; Culver J; Petucci C; Ma CT; Cohen SE; Tanaka J; Burgos ES; Hirschi JS; Smith SR; Sergienko E; Pinkerton AB Nat Commun; 2019 Jul; 10(1):3241. PubMed ID: 31324777 [TBL] [Abstract][Full Text] [Related]
11. Hyperthermophilic Archaeon Thermococcus kodakarensis Utilizes a Four-Step Pathway for NAD Hachisuka SI; Sato T; Atomi H J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29555696 [TBL] [Abstract][Full Text] [Related]
12. AMPK phosphorylates NAMPT to regulate NAD Liao X; Huang X; Li X; Qiu X; Li M; Liu R; He T; Tang Q Open Biol; 2022 Oct; 12(10):220213. PubMed ID: 36196536 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs). Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366 [TBL] [Abstract][Full Text] [Related]
14. A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT. Burgos ES; Ho MC; Almo SC; Schramm VL Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13748-53. PubMed ID: 19666527 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel nicotinamide phosphoribosyl transferase (NAMPT) inhibitor via in silico screening. Takeuchi M; Niimi T; Masumoto M; Orita M; Yokota H; Yamamoto T Biol Pharm Bull; 2014; 37(1):31-6. PubMed ID: 24389478 [TBL] [Abstract][Full Text] [Related]
16. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening. Ozgencil F; Eren G; Ozkan Y; Guntekin-Ergun S; Cetin-Atalay R Bioorg Med Chem; 2020 Jan; 28(1):115217. PubMed ID: 31818629 [TBL] [Abstract][Full Text] [Related]
17. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models. O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854 [TBL] [Abstract][Full Text] [Related]
18. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives. Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide phosphoribosyl transferase in mammary gland epithelial cells is required for nicotinamide mononucleotide production in mouse milk. Hattori K; Kobayashi K; Azuma-Suzuki R; Iwasa K; Higashi S; Hamaguchi T; Saito Y; Morifuji M; Nabeshima YI Biochem Biophys Res Commun; 2024 Oct; 728():150346. PubMed ID: 38972085 [TBL] [Abstract][Full Text] [Related]